β-Adrenergic Receptor Blockade in Chronic Heart Failure
Top Cited Papers
- 8 February 2000
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 101 (5), 558-569
- https://doi.org/10.1161/01.cir.101.5.558
Abstract
The failing human heart is adrenergically activated,4 5 6 which helps to maintain cardiac performance over the short term by increasing contractility and heart rate. In contrast, in the resting state there is no adrenergic support of normally functioning human left ventricles.6 Multiple lines of evidence7 8 9 indicate that it is the increase in cardiac adrenergic drive rather than an increase in circulating norepinephrine that is both initially supportive and then ultimately damaging to the failing human heart.Keywords
This publication has 98 references indexed in Scilit:
- Comparative hemodynamic effects of milrinone and dobutamine in heart failure patients treated chronically with carvedilolJournal of Cardiac Failure, 1998
- β-Adrenergic Blockers and Survival in Heart FailureNew England Journal of Medicine, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Dose Proportionality of Bisoprolol Enantiomers in Humans After Oral Administration of the RacemateThe Journal of Clinical Pharmacology, 1994
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- The Polymorphic Oxidation of ??-Adrenoceptor AntagonistsClinical Pharmacokinetics, 1986
- Rationale for beta-adrenergic blocking drugs in cardiomyopathyThe American Journal of Cardiology, 1985
- The Adrenergic Nervous System in Heart FailureNew England Journal of Medicine, 1984
- Unwanted effects of propranololThe American Journal of Cardiology, 1966